SỰ CHỈ RÕ

With the continuous development of the global pharmaceutical market, active pharmaceutical ingredients (APIs), as an important link in the pharmaceutical industry chain, occupy a significant position in the pharmaceutical industry. Their industrial development trends and competitive landscape have attracted widespread attention from the industry.

Competitive landscape:

In the current competitive landscape of the global API market, American companies have pharmaceutical patent advantages, Western European companies have process advantages, and API companies from developing countries such as India and China have relative cost advantages. As the world's largest producers of active pharmaceutical ingredients, China and India account for over 60% of the global supply of active pharmaceutical ingredients, making them the main producers and exporters of active pharmaceutical ingredients. In terms of production capacity, China has become the world's largest producer of active pharmaceutical ingredients.

From the perspective of raw material export trade, Indian manufacturing companies are actively catching up with China and have begun to increase India's share in the global raw material market, which will have a significant impact on the competition in the global raw material market.

Market demand:

North American market: As the world's largest raw material market, the North American market has stable growth, mainly due to the rapid development of biopharmaceuticals.

European market: The market is growing steadily, with high environmental and regulatory requirements, and companies need continuous investment to maintain competitiveness.

Asia Pacific market: China and India are the main production and export countries, and their market share continues to increase due to cost advantages and capacity expansion.

Latin American and Middle Eastern markets: These markets are growing rapidly, mainly driven by increased demand for generic drugs and improved medical infrastructure.

Future Trends:

The rise of biopharmaceuticals: With the expansion of the biopharmaceutical market, the demand for biopharmaceuticals will continue to increase. With the continuous advancement of technology, the global raw material market will gradually shift from chemically synthesized raw materials to biotechnology/biological raw materials.

The demand for generic drugs continues to grow: With the arrival of the wave of patent drug expiration, the generic drug market will continue to expand, driving the growth of demand for active pharmaceutical ingredients.

The global raw material market is in a rapid development stage, and by 2030, the global raw material market size is expected to exceed 300 billion US dollars, with a significant increase in the proportion of biopharmaceutical raw materials. China and India will continue to maintain their dominant position in global raw material supply, but the technological advantages of European and American countries in high value-added fields will be further strengthened.